.svg){kind=small}
Mar-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the ever-evolving cannabis market, Avexia has shown noteworthy performance across different states and categories, with a particularly strong presence in Illinois, Maryland, and Ohio. In Illinois, Avexia has maintained a consistent second place in the Capsules category from December 2023 through March 2024, despite a slight decrease in sales, indicating a strong and stable demand for their product. Additionally, their performance in the Topicals category is impressive, holding the first position across the same period with a significant sales rebound in March 2024. However, in the Concentrates category, their ranking fluctuated, improving from 20th to 15th by March 2024, which suggests a positive momentum that could be capitalized on with strategic marketing efforts.
On the other hand, Avexia's performance in Massachusetts and Nevada offers a mixed picture. In Massachusetts, their Concentrates category saw a remarkable improvement, moving from not being in the top 30 in December 2023 to holding the 20th position by March 2024, which could indicate a growing market presence or successful product introductions. Their Topicals also experienced upward movement, advancing from the 8th to the 4th position, showing a strong consumer preference. However, in Nevada, while they maintained a steady performance in the Tincture & Sublingual category, their Topicals category saw a slight decline, moving from 4th to 6th position, which might signal a need for review of their market strategy or product offerings in this segment. Avexia's overall performance indicates a brand with strengths to build upon and areas for strategic improvement, reflecting the dynamic nature of consumer preferences and market competition.
Competitive Landscape
In the competitive landscape of the topical cannabis market in Illinois, Avexia has maintained a dominant position, consistently ranking as the number one brand from December 2023 through March 2024. Its closest competitors, Doctor Solomon's and Nature's Grace and Wellness, have also held steady in their rankings at second and third place, respectively, during the same period. Despite fluctuations in sales across the board for these top brands, Avexia's sales have remained significantly higher than those of Doctor Solomon's and Nature's Grace and Wellness, showcasing its strong market presence and consumer preference. This consistent leadership in the topical category underscores Avexia's robust position in the Illinois market, suggesting a well-established brand loyalty and a successful product line that resonates with consumers. The stability in rankings among these top competitors indicates a competitive but stable market dynamic, with Avexia leading the way in terms of sales performance and market share.
Notable Products
In Mar-2024, Avexia's top-performing product was the CBD/THC 1:1 Harmony Pain Relief Balm (100mg CBD, 100mg THC, 2oz) in the Topical category, maintaining its number one rank from previous months with sales reaching 11,125 units. Following in second place, the CBD/THC 4:1 Relief Tablets 40-Pack (400mg CBD, 100mg THC) from the Capsules category also held its position with consistent performance. The CBN/CBD/THC 1:1:1 Comfort Tablets 40-Pack (100mg CBN, 100mg CBD, 100mg THC) secured the third rank, showing steady demand in the Capsules category without any rank changes over the months. The fourth spot was claimed by the CBD/THC 1:1 Harmony Micro-Dosed Tablets 40-Pack (100mg CBD,100mg THC), indicating a strong preference among consumers for capsule forms of cannabis products. Notably, the Lavender Epsom Bath Soak (100mg THC, 6oz) made a re-entry into the top five in Mar-2024, highlighting a diverse consumer interest in both Topical and Capsule categories.
Top Selling Cannabis Brands
